The EPIPEN Savings Card
It’s a savings offer that may provide commercially insured, eligible patients up to $300* in out-of-pocket savings for each EPIPEN 2-PAK®
and/or EPIPEN JR 2-PAK® carton—up to three cartons (six Auto-Injectors) per prescription fill, so patients have immediate access to an
EPIPEN 2-PAK and/or EPIPEN JR 2-PAK cartons in multiple locations.
The Epinephrine Injection, USP Auto-Injector Savings Card
It's a savings offer that may provide commercially insured, eligible patients up to $25* in out-of-pocket savings for each two-pack carton of the Epinephrine Injection, USP Auto-Injector (The authorized generic to EPIPEN)—up to three cartons (six Auto-Injectors) per prescription fill, so patients have immediate access to a two-pack in multiple locations.
Patients can find out if they’re eligible here
*Certain restrictions apply. See full Terms and Conditions for the EPIPEN Savings Card here and the Epinephrine Injection, USP Auto-Injector Card Savings card here. These savings offers are not valid for patients covered by Medicare, Medicaid or any other federal or state funded healthcare program or where prohibited by law. Mylan Specialty L.P., a Viatris Company, reserves the right to amend or end this program at any time without notice.
Viatris' Patient Assistance Program
At Viatris, we believe financial circumstances should not be a barrier to proper healthcare needs. The Viatris Patient Assistance Program provides certain medicines for free to patients with a demonstrated financial need. For information and contact details, please visit Viatris Patient Assistance Program (U.S.)
EPIPEN4SCHOOLS®
With the EPIPEN4SCHOOLS program, Mylan Specialty L.P., a Viatris Company offers four free EPIPEN (epinephrine injection, USP) or EPIPEN JR® (epinephrine injection, USP) Auto-Injectors in the form of two EPIPEN 2-PAK cartons, two EPIPEN JR 2-PAK cartons or one 2-Pak of each kind, upon qualification, which includes having a valid prescription, to public and private kindergarten, elementary, middle and high schools in the US. Schools may receive the authorized generic versions of EPIPEN and EPIPEN JR.
To participate in EPIPEN4SCHOOLS, a school nurse or other authorized school representative must visit WWW.EPIPEN4SCHOOLS.COM to download the order and certification form, and then fax or email the form with a valid prescription to 1-973-718-4328 or info@bioridgepharma.com Alternatively, school representatives can call 1-973-845-7600 to speak with a live representative. There is no requirement for a school to purchase additional EPIPEN Auto-Injectors or any other Viatris Inc. products.
Special Offers
Viatris offers Access and Savings Programs for eligible patients. See Terms and Conditions.
There’s only one recommended first line treatment for anaphylaxis.
heading
Important Safety Information (the following information applies to both EPIPEN and its Authorized Generic)
EPIPEN (epinephrine injection, USP) 0.3 mg and EPIPEN JR (epinephrine injection, USP) 0.15 mg Auto-Injectors are intended for immediate administration as emergency supportive therapy only and are not intended as a substitute for immediate medical or hospital care. In conjunction with the administration of epinephrine, the patient should seek immediate medical or hospital care. More than two sequential doses of epinephrine should only be administered under direct medical supervision.
Rare cases of serious skin and soft tissue infections have been reported following epinephrine injection.
Important Safety Information (the following information applies to both Epipen and its Authorized Generic)
EPIPEN (epinephrine injection, USP) 0.3 mg and EPIPEN JR (epinephrine injection, USP) 0.15 mg Auto-Injectors are intended for immediate administration as emergency supportive therapy only and are not intended as a substitute for immediate medical or hospital care. In conjunction with the administration of epinephrine, the patient should seek immediate medical or hospital care. More than two sequential doses of epinephrine should only be administered under direct medical supervision.
EPIPEN and EPIPEN JR should only be injected into the anterolateral aspect of the thigh. Do not inject intravenously, into buttock, or into digits, hands, or feet. Instruct caregivers to hold the leg of young children firmly in place and limit movement prior to and during injection to minimize risk of injection-related injury.
Rare cases of serious skin and soft tissue infections have been reported following epinephrine injection. Advise patients to seek medical care if they develop symptoms of infection such as persistent redness, warmth, swelling, or tenderness at the injection site.
Epinephrine should be used with caution in patients with heart disease, and in patients who are on drugs that may sensitize the heart to arrhythmias, because it may precipitate or aggravate angina pectoris and produce ventricular arrhythmias. Arrhythmias, including fatal ventricular fibrillation, have been reported, particularly in patients with underlying cardiac disease or taking cardiac glycosides, diuretics, or anti-arrhythmics.
Patients with certain medical conditions or who take certain medications for allergies, depression, thyroid disorders, diabetes, and hypertension, may be at greater risk for adverse reactions. Common adverse reactions to epinephrine include anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.
Indications (the following information applies to both EPIPEN and its Authorized Generic)
EPIPEN and EPIPEN JR Auto-Injectors are indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. EPIPEN and EPIPEN JR Auto-Injectors are intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.
Click here for Full Prescribing Information for EPIPEN.
Click here for Full Prescribing Information for the Authorized Generic for EPIPEN.
EPIPEN®, EPIPEN JR®, EPIPEN 2-PAK®, EPIPEN JR 2-PAK®, EPIPEN4SCHOOLS®, NEVER-SEE-NEEDLE® and the EPIPEN® Logo are registered trademarks of Mylan Inc., a Viatris Company. VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris Company. All other trademarks and service marks are the property of their respective owners. This website is intended for residents of the United States who will prescribe or fill prescriptions for patients located within the United States.
© 2023 Viatris Inc. All Rights Reserved. EPI-2021-0172 V6
EPIPEN®, EPIPEN JR®, EPIPEN 2-PAK®, EPIPEN JR 2-PAK®, EPIPEN4SCHOOLS®, NEVER-SEE-NEEDLE® and the EPIPEN® Logo are registered trademarks of Mylan Inc., a Viatris Company. VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris Company. All other trademarks and service marks are the property of their respective owners. This website is intended for residents of the United States who will prescribe or fill prescriptions for patients located within the United States.
© 2023 Viatris Inc. All Rights Reserved. EPI-2021-0172 V6
This site is intended for US healthcare professionals.
If you are a patient, please check out our site for patients.
Prescribing Information
Please select from the following:
Patient Information
Please select from the following: